CompletedNot Applicable

Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease

United Kingdom113 participantsStarted 2018-10-04

Plain-language summary

The aim of this study is to assess whether prehabilitation supervised by an appropriate multimodality team improves indices of sarcopenia in patients scheduled to undergo pancreatoduodenectomy.

Who can participate

Age range16 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients treated by pancreatic resection
✓. Surgery for malignancy
✓. Patients aged over 16
✓. CT scans available for assessment

Exclusion criteria

✕. Patients scheduled for fast-track pancreatic resection as part of the jaundice pathway
✕. Aged under 16
✕. Patients not undergoing pancreatic resection

What they're measuring

CT Scan Comparison

Timeframe: Within last 5 years.

Trial details

NCT IDNCT03770117

SponsorManchester University NHS Foundation Trust

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2019-07-01

View on ClinicalTrials.gov More Pancreatic Ductal Adenocarcinoma trials